The Executive Board forecasts full-year total revenues for the Group to be about € 10 billion to € 10.2 billion. Likewise, the Executive Board expects the Group underlying core operating result for 2011 to amount to about € 2.25 billion, as stated in July. The net financial debt of the Merck Group resulting from the 2010 acquisition of Millipore continues to decrease at an excellent pace.
|
Merck Guidance for 2011 |
|
|
|
|
|
Merck Group |
Expectations 2011 |
|
Total Revenues |
~ € 10 – € 10.2 billion |
|
Operating Result |
~ € 1.0 billion |
|
Underlying Core Operating Result |
~ € 2.25 billion |
| XLS |
|
Merck Divisions |
Total Revenues Growth 2011 | ||
| |||
|
Merck Serono |
~ 1–2% | ||
|
Consumer Health Care |
~ 5–6% | ||
|
Merck Millipore* |
~ 47% | ||
|
Performance Materials* |
~ 3–4% | ||
back
